BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration
Business Wire•10/08/2026•06:00 ET
0
Whiz Insights
BeOne Medicines and Revolution Medicines Announce Clinical Development and Regional Commercialization Collaboration
Clinical collaboration enables novel combinations of select BeOne oncology assets with four Revolution Medicines clinical-stage RAS(ON) inhibitors for RAS-addicted cancers
Get started
Create a free account to read the full story.